It's time to move from the A1c to better metrics for diabetes control

Diabetes Technology and Therapeutics

Volumn 15, Issue 3, 2013, Pages 194-196

  Kowalski, Aaron J ^a   Dutta, Sanjoy ^a  

^a Juvenile Diabetes Research Foundation International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETES MELLITUS; ERYTHROCYTE LIFESPAN; GLUCOSE BLOOD LEVEL; GLYCATION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; NOTE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN INFUSION SYSTEMS; MALE; STANDARD OF CARE;

EID: 84875195136     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0060     Document Type: Note

References (23)

1. Diabetes Mellitus Interagency Coordinating Committee. Strategic Planning to Enhance Federal Diabetes Programs, August 11, 2008. http://archives.niddk. nih.gov/federal/dmicc/ 2005/12-12-05/summary.pdf (accessed February 19, 2013
2. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA; the T1D Exchange Clinic Network: The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012;97:4383-4389
3. Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM: Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: The Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 2013;15:198-211
4. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ: Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience (1983- 2005). Arch Intern Med 2009;169:1307-1316
5. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986
6. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865
7. DCCT/EDIC Research Group, de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B: Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011;365:2366-2376
8. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167
9. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY; Meta-Analysis for Eye Disease (META-EYE) Study Group: Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-564
10. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A: Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 1976;295: 417-420
11. Cryer PE: Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes. Diabetologia 2002;45:937-948 (Pubitemid 34762188)
12. Cryer PE: Severe hypoglycemia predicts mortality in diabetes. Diabetes Care 2012;35:1814-1816
13. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) Trial. Diabetes Care 2010;33:17-22
14. JDRF CGM Study Group: JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: Research design and methods. Diabetes Technol Ther 2008;10: 310-321
15. Ruedy KJ, Tamborlane WV: The landmark JDRF continuous glucose monitoring randomized trials: A look back at the accumulated evidence: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. J Cardiovasc Transl Res 2012;5:380-387
16. Kowalski AJ: Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: A roadmap to better diabetes outcomes. Diabetes Technol Ther 2009;11(Suppl 1):S-113-S-119
17. Hirsch IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005;19:178-181 (Pubitemid 40615551)
18. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH: Glucose variability; does it matter? Endocr Rev 2010;31:171-182
19. Monnier L, Wojtusciszyn A, Colette C, Owens D: The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther 2011;13:813-818
20. Qu Y, Jacober S, Zhang Q, Wolka L, DeVries JH: Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data. Diabetes Technol Ther 2012;14:1008-1012
21. Wood JR, Miller KM, Maahs DM, Beck RW, Dimeglio LA, Libman IM, Quinn M, Tamborlane WV, Woerner SE; T1D Exchange Clinic Network: Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 2013 Jan 22 [Epub ahead of print]. doi: 10.2337/dc12-1959
22. Nimri R, Atlas E, Ajzensztejn M, Miller S, Oron T, Phillip M: Feasibility study of automated overnight closed-loop glucose control under MD-Logic artificial pancreas in patients with type 1 diabetes: The DREAM Project. Diabetes Technol Ther 2012;14:728-735
23. Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R: Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes 2012;13:449-453